RECURSION PHARMACEUTICALS, INC. - Class A Stock (RXRX)
CUSIP: 75629V104
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Class A Stock
- Shares outstanding
- 525,302,736
- Total 13F shares
- 324,190,091
- Share change
- +13,988,556
- Total reported value
- $1,581,950,465
- Put/Call ratio
- 63%
- Price per share
- $4.88
- Number of holders
- 321
- Value change
- +$66,787,219
- Number of buys
- 174
- Number of sells
- 127
Quarterly Holders Quick Answers
What is CUSIP 75629V104?
CUSIP 75629V104 identifies RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 75629V104:
Top shareholders of RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
6.9%
|
36,071,178
|
$182,520,161 | — | 30 Jun 2025 | |
| ARK Investment Management LLC |
13F
|
Company |
6.3%
|
32,988,631
|
$166,922,471 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
5.4%
|
28,371,063
|
$143,557,577 | — | 30 Jun 2025 | |
| Lux Ventures IV, L.P. |
3/4/5
|
Former 10% Owner |
—
class O/S missing
|
13,021,519
|
$137,710,376 | — | 07 Dec 2021 | |
| Mubadala Investment Co PJSC |
3/4/5
13F
|
10%+ Owner · Company |
2.5%
from 13F
|
12,985,927
|
$137,333,970 | — | 02 Mar 2023 | |
| BAILLIE GIFFORD & CO |
13F
13D/G
|
Company |
6.5%
from 13D/G
|
24,173,815
|
$122,319,504 | — | 30 Jun 2025 | |
| SOFTBANK GROUP CORP. |
13F
|
Company |
2.8%
|
14,667,491
|
$74,217,504 | — | 30 Jun 2025 | |
| Kinnevik AB (publ) |
13F
|
Company |
2.6%
|
13,434,171
|
$67,976,906 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.1%
|
11,179,539
|
$56,568,467 | — | 30 Jun 2025 | |
| Novo Holdings A/S |
13F
|
Company |
1.8%
|
9,665,128
|
$48,905,548 | — | 30 Jun 2025 | |
| MIC Capital Management UK LLP |
13F
|
Company |
1.8%
|
9,644,032
|
$48,798,807 | — | 30 Jun 2025 | |
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
|
— |
2%
|
7,725,096
|
$44,187,549 | $0 | 31 Dec 2024 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
1.6%
|
8,167,745
|
$41,328,790 | — | 30 Jun 2025 | |
| Amova Asset Management Americas, Inc. |
13F
|
Company |
1.6%
|
8,167,745
|
$41,247,112 | — | 30 Jun 2025 | |
| Zachary Bogue |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
3,736,341
|
$39,514,048 | — | 03 Jul 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
7,776,408
|
$39,353,010 | — | 30 Jun 2025 | |
| NVIDIA CORP |
13F
|
Company |
1.5%
|
7,706,363
|
$38,994,197 | — | 30 Jun 2025 | |
| Data Collective IV GP, LLC |
13F
|
Company |
1.1%
|
5,941,120
|
$30,062,067 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.1%
|
5,689,612
|
$28,789,445 | — | 30 Jun 2025 | |
| FMR LLC |
13F
|
Company |
1.1%
|
5,584,858
|
$28,259,381 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.88%
|
4,630,590
|
$23,430,785 | — | 30 Jun 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.88%
|
4,615,516
|
$23,354,511 | — | 30 Jun 2025 | |
| DCVC Opportunity Fund II GP, LLC |
13F
|
Company |
0.75%
|
3,951,141
|
$19,992,773 | — | 30 Jun 2025 | |
| Lingotto Investment Management LLP |
13F
|
Company |
0.7%
|
3,675,077
|
$18,595,890 | — | 30 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.61%
|
3,205,339
|
$16,219,015 | — | 30 Jun 2025 | |
| NORGES BANK |
13F
|
Company |
0.6%
|
3,169,938
|
$16,039,886 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.55%
|
2,914,872
|
$14,749,252 | — | 30 Jun 2025 | |
| MIC Capital Partners (Public) Parallel Cayman, LP |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,388,889
|
$14,688,335 | — | 01 Nov 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.49%
|
2,589,202
|
$13,101,362 | — | 30 Jun 2025 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.36%
|
1,880,290
|
$9,514,267 | — | 30 Jun 2025 | |
| Michael Secora |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
1,836,074
mixed-class rows
|
$9,186,510 | — | 15 Nov 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.26%
|
1,378,915
|
$6,977,309 | — | 30 Jun 2025 | |
| Vestmark Advisory Solutions, Inc. |
13F
|
Company |
0.25%
|
1,339,139
|
$6,776,044 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.25%
|
1,314,552
|
$6,651,633 | — | 30 Jun 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.23%
|
1,225,658
|
$6,201,829 | — | 30 Jun 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.22%
|
1,167,813
|
$5,909,134 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.22%
|
1,164,689
|
$5,893,327 | — | 30 Jun 2025 | |
| Jump Financial, LLC |
13F
|
Company |
0.22%
|
1,151,201
|
$5,825,077 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.22%
|
1,131,218
|
$5,723,963 | — | 30 Jun 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.21%
|
1,081,203
|
$5,470,888 | — | 30 Jun 2025 | |
| Comprehensive Financial Management LLC |
13F
|
Company |
0.18%
|
941,895
|
$4,765,989 | — | 30 Jun 2025 | |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd |
13F
|
Company |
0.17%
|
911,085
|
$4,610,090 | — | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.14%
|
739,408
|
$3,741,404 | — | 30 Jun 2025 | |
| CAPITAL FUND MANAGEMENT S.A. |
13F
|
Company |
0.14%
|
720,526
|
$3,645,861 | — | 30 Jun 2025 | |
| Liontrust Investment Partners LLP |
13F
|
Company |
0.13%
|
702,386
|
$3,554,073 | — | 30 Jun 2025 | |
| Nan Fung Group Holdings Ltd |
13F
|
Company |
0.13%
|
664,610
|
$3,362,927 | — | 30 Jun 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.12%
|
633,403
|
$3,205,019 | — | 30 Jun 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.12%
|
631,206
|
$3,193,902 | — | 30 Jun 2025 | |
| Tina Marriott |
3/4/5
|
President and COO |
—
mixed-class rows
|
954,769
mixed-class rows
|
$3,129,811 | — | 15 Nov 2024 | |
| Pivotal bioVenture Partners Investment Advisor LLC |
13F
|
Company |
0.11%
|
595,518
|
$3,013,321 | — | 30 Jun 2025 |
Institutional Holders of RECURSION PHARMACEUTICALS, INC. - Class A Stock (RXRX) as of Q3 2025
As of 30 Sep 2025,
RECURSION PHARMACEUTICALS, INC. - Class A Stock (RXRX) was held by
321 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
324,190,091 shares.
The largest 10 holders included
VANGUARD GROUP INC, ARK Investment Management LLC, BlackRock, Inc., BAILLIE GIFFORD & CO, STATE STREET CORP, SOFTBANK GROUP CORP., KINNEVIK AB (PUBL), Mubadala Investment Co PJSC, MIC Capital Management UK LLP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
321
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
329
Q3 2025 holders
321
Holder diff
-8
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.